COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AbbVie Inc. | Common | 00287Y109 | 2,975 | 27,769 | SH | | DFND | 2 | 27,769 | 0 | 0 |
AbbVie Inc. | Common | 00287Y109 | 536 | 5,000 | SH | | DFND | 2 | 5,000 | 0 | 0 |
AC Immune SA | Common | H00263105 | 27 | 5,309 | SH | | DFND | 2 | 5,309 | 0 | 0 |
ADMA Biologics, Inc. | Common | 000899104 | 42 | 21,457 | SH | | DFND | 2 | 21,457 | 0 | 0 |
Alexion Pharamaceuticals, Inc. | Common | 015351109 | 1,648 | 10,545 | SH | | DFND | 2 | 10,545 | 0 | 0 |
Alerian MLP | Common | 00162Q452 | 3 | 120 | SH | | DFND | 1 | 120 | 0 | 0 |
Alimera Sciences, Inc. | Common | 016259202 | 338 | 80,194 | SH | | DFND | 2 | 80,194 | 0 | 0 |
Alphabet Inc-Cl C | Common | 02079K107 | 9,811 | 5,600 | SH | | DFND | 2 | 5,600 | 0 | 0 |
ALX Oncology. Inc | Common | 00166B105 | 276 | 3,200 | SH | | DFND | 2 | 3,200 | 0 | 0 |
AllianceBernstein Holding PL Unit Ltd. | Common | 01881G106 | 51 | 1,500 | SH | | DFND | 1 | 1,500 | 0 | 0 |
AllianceBernstein Holding PL Unit Ltd. | Common | 01881G106 | 1,655 | 49,000 | SH | | DFND | 1 | 49,000 | 0 | 0 |
Apollo Global Management, Inc. | Common | 03768E105 | 14,694 | 300,000 | SH | | DFND | 2 | 300,000 | 0 | 0 |
Apple Inc. | Common | 037833100 | 279 | 2,100 | SH | | DFND | 1 | 2,100 | 0 | 0 |
AT&T Inc. | Common | 00206R102 | 59 | 2,050 | SH | | DFND | 1 | 2,050 | 0 | 0 |
AT&T Inc. | Common | 00206R102 | 575 | 20,000 | SH | | DFND | 1 | 20,000 | 0 | 0 |
Aurinia Pharmaceuticals Inc. | Common | 05156V102 | 2,455 | 177,540 | SH | | DFND | 2 | 177,540 | 0 | 0 |
Avadel Pharmaceuticals plc | Common | 05337M104 | 581 | 86,916 | SH | | DFND | 2 | 86,916 | 0 | 0 |
Axovant Gene Therapeutic, Ltd | Common | G0750W104 | 111 | 40,000 | SH | | DFND | 2 | 40,000 | 0 | 0 |
Bank Nova Scotia Halifax | Common | 064149107 | 22 | 400 | SH | | DFND | 1 | 400 | 0 | 0 |
BioCryst Pharmaceuticals, Inc. | Common | 09058V103 | 1,635 | 219,461 | SH | | DFND | 2 | 219,461 | 0 | 0 |
BioDelivery Sciences International, Inc. | Common | 09060J106 | 1,555 | 370,230 | SH | | DFND | 2 | 370,230 | 0 | 0 |
Bristol-Myers Squibb Company | Common | 110122108 | 3,251 | 52,409 | SH | | DFND | 2 | 52,409 | 0 | 0 |
Bristol-Myers Squibb Company - CVR | Common | 110122157 | 45 | 64,720 | SH | | DFND | 2 | 64,720 | 0 | 0 |
Calumet Specialty Products Partners, LP | Common | 131476103 | 8,216 | 2,625,000 | SH | | DFND | 2 | 2,625,000 | 0 | 0 |
Calumet Specialty Products Partners, LP | Common | 131476103 | 63 | 20,000 | SH | | DFND | 1 | 20,000 | 0 | 0 |
Canadian Natural Resources Inc. | Common | 136385101 | 440 | 18,285 | SH | | DFND | 1 | 18,285 | 0 | 0 |
Canadian Natural Resources Inc. | Common | 136385101 | 96 | 4,000 | SH | | DFND | 1 | 4,000 | 0 | 0 |
Capitol Investment Corp. V | Common | 14064F209 | 2,575 | 250,000 | SH | | DFND | 2 | 250,000 | 0 | 0 |
Capitol Federal S&L | Common | 14057J101 | 73 | 5,800 | SH | | DFND | 1 | 5,800 | 0 | 0 |
Check Cap Ltd. | Common | M2361E203 | 1 | 2,224 | SH | | DFND | 2 | 2,224 | 0 | 0 |
Chemours Co. | Common | 163851108 | 18 | 720 | SH | | DFND | 1 | 720 | 0 | 0 |
Chemours Co. | Common | 163851108 | 11 | 440 | SH | | DFND | 1 | 440 | 0 | 0 |
Cidara Therapeutics, Inc. | Common | 171757107 | 831 | 415,308 | SH | | DFND | 2 | 415,308 | 0 | 0 |
Coca Cola | Common | 191216100 | 318 | 5,800 | SH | | DFND | 1 | 5,800 | 0 | 0 |
Coca Cola | Common | 191216100 | 417 | 7,600 | SH | | DFND | 1 | 7,600 | 0 | 0 |
Coherus Biosciences, Inc. | Common | 19249H103 | 1,767 | 101,655 | SH | | DFND | 2 | 101,655 | 0 | 0 |
Colony Cap Inc. | Common | 19626G108 | 7 | 1,466 | SH | | DFND | 1 | 1,466 | 0 | 0 |
Conagra Brands | Common | 205887102 | 363 | 10,000 | SH | | DFND | 1 | 10,000 | 0 | 0 |
Constellation Phamaceuticals, Inc. | Common | 210373106 | 950 | 33,000 | SH | | DFND | 2 | 33,000 | 0 | 0 |
Corveta Inc. | Common | 22052L104 | 58 | 1,494 | SH | | DFND | 1 | 1,494 | 0 | 0 |
Corveta Inc. | Common | 22052L104 | 428 | 11,051 | SH | | DFND | 1 | 11,051 | 0 | 0 |
Cousins Properties | Common | 222795502 | 112 | 3,357 | SH | | DFND | 1 | 3,357 | 0 | 0 |
CTI BioPharma Corp. | Common | 12648L601 | 64 | 20,000 | SH | | DFND | 2 | 20,000 | 0 | 0 |
Danimer Scientific, Inc. | Common | 236272100 | 11,755 | 500,000 | SH | | DFND | 2 | 500,000 | 0 | 0 |
DFP Healthcare Acquistions Corp. | Common | 23343Q209 | 11 | 1,000 | SH | | DFND | 2 | 1,000 | 0 | 0 |
Dow Inc. | Common | 260557103 | 83 | 1,494 | SH | | DFND | 1 | 1,494 | 0 | 0 |
Dow Inc. | Common | 260557103 | 590 | 10,624 | SH | | DFND | 1 | 10,624 | 0 | 0 |
Dupont De Nemours Inc. | Common | 26614N102 | 106 | 1,494 | SH | | DFND | 1 | 1,494 | 0 | 0 |
Dupont De Nemours Inc. | Common | 26614N102 | 755 | 10,624 | SH | | DFND | 1 | 10,624 | 0 | 0 |
Eagle Materials | Common | 26969P108 | 23 | 228 | SH | | DFND | 1 | 228 | 0 | 0 |
Eastern Bankshares Inc | Common | 27627N105 | 3,099 | 190,000 | SH | | DFND | 2 | 190,000 | 0 | 0 |
Eastern Bankshares Inc | Common | 27627N105 | 163 | 10,000 | SH | | DFND | 1 | 10,000 | 0 | 0 |
Editas Medicine Inc. | Common | 28106W103 | 421 | 6,000 | SH | | DFND | 2 | 6,000 | 0 | 0 |
Eiger BioPharmaceuticals, Inc. | Common | 28249U105 | 3,626 | 295,035 | SH | | DFND | 2 | 295,035 | 0 | 0 |
Eli Lilly Inc. | Common | 532457108 | 51 | 300 | SH | | DFND | 1 | 300 | 0 | 0 |
FibroGen, Inc. | Common | 31572Q808 | 371 | 10,000 | SH | | DFND | 2 | 10,000 | 0 | 0 |
FNB Corporation | Common | 302520101 | 85 | 8,905 | SH | | DFND | 1 | 8,905 | 0 | 0 |
Fortress Trans & Infrastructure Inv. LLC | Common | 34960P101 | 16,422 | 700,000 | SH | | DFND | 2 | 700,000 | 0 | 0 |
FS Bancorp | Common | 30263Y104 | 116 | 2,117 | SH | | DFND | 1 | 2,117 | 0 | 0 |
FS Bancorp | Common | 30263Y104 | 80 | 1,460 | SH | | DFND | 1 | 1,460 | 0 | 0 |
FS KKR Capital Corp. | Common | 302635206 | 5,796 | 350,000 | SH | | DFND | 2 | 350,000 | 0 | 0 |
FS KKR Capital Corp. | Common | 302635206 | 266 | 16,050 | SH | | DFND | 1 | 16,050 | 0 | 0 |
FS KKR Capital Corp. | Common | 302635206 | 482 | 29,125 | SH | | DFND | 1 | 29,125 | 0 | 0 |
General Electric | Common | 369604103 | 38 | 3,480 | SH | | DFND | 1 | 3,480 | 0 | 0 |
General Electric | Common | 369604103 | 13 | 1,200 | SH | | DFND | 1 | 1,200 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 3,778 | 64,842 | SH | | DFND | 2 | 64,842 | 0 | 0 |
Globus Medical, Inc. | Common | 379577208 | 302 | 4,631 | SH | | DFND | 2 | 4,631 | 0 | 0 |
Heritage NOLA Bancorp Inc. | Common | 42727P108 | 110 | 9,000 | SH | | DFND | 1 | 9,000 | 0 | 0 |
Horizon Aquistion Corporation | Common | G46049105 | 2,105 | 210,100 | SH | | DFND | 2 | 210,100 | 0 | 0 |
Horizon Therapeutics Public Ltd. Company | Common | G46188101 | 3,117 | 42,614 | SH | | DFND | 2 | 42,614 | 0 | 0 |
International Business Machines | Common | 459200101 | 539 | 4,284 | SH | | DFND | 1 | 4,284 | 0 | 0 |
International Gaming Technologies | Common | G4863A108 | 1,694 | 100,000 | SH | | DFND | 2 | 100,000 | 0 | 0 |
International Gaming Technologies | Common | G4863A108 | 127 | 7,500 | SH | | DFND | 1 | 7,500 | 0 | 0 |
iPath Series B S&P 500 VIX Short-Term Fut | Common | 06746P621 | 3,358 | 200,000 | SH | | DFND | 2 | 200,000 | 0 | 0 |
iShares Nasdaq Biotechnology ETF | Common | 464287556 | 151 | 1,000 | SH | | DFND | 2 | 1,000 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 799 | 5,080 | SH | | DFND | 1 | 5,080 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 157 | 1,000 | SH | | DFND | 1 | 1,000 | 0 | 0 |
JP Morgan Chase | Common | 46625H100 | 1,811 | 14,250 | SH | | DFND | 1 | 14,250 | 0 | 0 |
JP Morgan Chase | Common | 46625H100 | 727 | 5,720 | SH | | DFND | 1 | 5,720 | 0 | 0 |
Kadmon Holdings, Inc. | Common | 48283N106 | 2,913 | 702,000 | SH | | DFND | 2 | 702,000 | 0 | 0 |
Kimberly Clark Corporation | Common | 494368103 | 809 | 6,000 | SH | | DFND | 1 | 6,000 | 0 | 0 |
Kennedy-Wilson Holdings, Inc. | Common | 489398107 | 3,757 | 210,000 | SH | | DFND | 2 | 210,000 | 0 | 0 |
KKR & Co. Inc. | Common | 48251W104 | 4,049 | 100,000 | SH | | DFND | 2 | 100,000 | 0 | 0 |
Leap Therapeutics, Inc. | Common | 52187K101 | 22 | 9,700 | SH | | DFND | 2 | 9,700 | 0 | 0 |
Legacy Housing Corporation | Common | 52472M101 | 76 | 5,000 | SH | | DFND | 1 | 5,000 | 0 | 0 |
Legacy Housing Corporation | Common | 52472M101 | 60 | 4,000 | SH | | DFND | 1 | 4,000 | 0 | 0 |
Ligand Pharmaceuticals Incorporated | Common | 53220K504 | 23,589 | 237,198 | SH | | DFND | 2 | 237,198 | 0 | 0 |
Ligand Pharmaceuticals Incorporated | Common | 53220K504 | 895 | 9,000 | SH | | DFND | 1 | 9,000 | 0 | 0 |
Ligand Pharmaceuticals Incorporated | Common | 53220K504 | 183 | 1,843 | SH | | DFND | 1 | 1,843 | 0 | 0 |
LKQ Corporation | Common | 501889208 | 4,229 | 120,000 | SH | | DFND | 2 | 120,000 | 0 | 0 |
Longview Aquisition Corp. | Common | 543195101 | 364 | 18,380 | SH | | DFND | 2 | 18,380 | 0 | 0 |
Marinus Pharmaceutical, Inc. | Common | 56854Q200 | 305 | 25,000 | SH | | DFND | 2 | 25,000 | 0 | 0 |
Macquarie Infrastructure Corporation | Common | 55608B105 | 124 | 3,300 | SH | | DFND | 1 | 3,300 | 0 | 0 |
Macquarie Infrastructure Corporation | Common | 55608B105 | 370 | 9,850 | SH | | DFND | 1 | 9,850 | 0 | 0 |
Medtronics | Common | G5960L103 | 123 | 1,050 | SH | | DFND | 1 | 1,050 | 0 | 0 |
Merck & Co. Inc. | Common | 58993Y105 | 65 | 800 | SH | | DFND | 1 | 800 | 0 | 0 |
Merck & Co. Inc. | Common | 58993Y105 | 41 | 500 | SH | | DFND | 1 | 500 | 0 | 0 |
Microsoft Corporation | Common | 594918104 | 89 | 400 | SH | | DFND | 1 | 400 | 0 | 0 |
Microsoft Corporation | Common | 594918104 | 222 | 1,000 | SH | | DFND | 1 | 1,000 | 0 | 0 |
Midwest Holdings Inc. | Common | 59833J206 | 7,705 | 143,621 | SH | | DFND | 2 | 143,621 | 0 | 0 |
Mondelez Int'l Inc. | Common | 609207105 | 170 | 2,900 | SH | | DFND | 1 | 2,900 | 0 | 0 |
Mondelez Int'l Inc. | Common | 609207105 | 760 | 13,000 | SH | | DFND | 1 | 13,000 | 0 | 0 |
MPLX LP | Common | 55336V100 | 2,165 | 100,000 | SH | | DFND | 2 | 100,000 | 0 | 0 |
Occidental Pete Corp | Common | 674599105 | 29 | 1,700 | SH | | DFND | 1 | 1,700 | 0 | 0 |
Occidental Pete Corp | Common | 674599105 | 22 | 1,273 | SH | | DFND | 1 | 1,273 | 0 | 0 |
Occidental Pete Corp Wts exp 8/3/27 | Common | 674599162 | 5 | 212 | SH | | DFND | 1 | 212 | 0 | 0 |
Occidental Pete Corp Wts exp 8/3/27 | Common | 674599162 | 3 | 158 | SH | | DFND | 1 | 158 | 0 | 0 |
Peoples United Financial | Common | 712704105 | 19 | 1,500 | SH | | DFND | 1 | 1,500 | 0 | 0 |
Pfizer Inc. | Common | 717081103 | 1,137 | 30,900 | SH | | DFND | 1 | 30,900 | 0 | 0 |
Pfizer Inc. | Common | 717081103 | 3,276 | 89,000 | SH | | DFND | 1 | 89,000 | 0 | 0 |
Protara Therapeutics, Inc. | Common | 74365U107 | 348 | 14,369 | SH | | DFND | 2 | 14,369 | 0 | 0 |
Quotient Technology Inc. | Common | 749119103 | 471 | 50,000 | SH | | DFND | 2 | 50,000 | 0 | 0 |
Radius Health Inc. | Common | 750469207 | 447 | 25,034 | SH | | DFND | 2 | 25,034 | 0 | 0 |
Reinvent Technology Partners | Common | G7483N129 | 2,037 | 176,226 | SH | | DFND | 2 | 176,226 | 0 | 0 |
Relmada Therapeutics, Inc. | Common | 75955J402 | 96 | 3,000 | SH | | DFND | 2 | 3,000 | 0 | 0 |
RMR Group Inc. | Common | 74967R106 | 1 | 16 | SH | | DFND | 1 | 16 | 0 | 0 |
Ryman Hospitality Ppty Inc. | Common | 78377T107 | 27 | 400 | SH | | DFND | 1 | 400 | 0 | 0 |
Ryman Hospitality Ppty Inc. | Common | 78377T107 | 813 | 12,000 | SH | | DFND | 1 | 12,000 | 0 | 0 |
Sculptor Capital Management | Common | 811246107 | 3 | 200 | SH | | DFND | 1 | 200 | 0 | 0 |
Service Ppty Trust | Common | 81761L102 | 11 | 1,000 | SH | | DFND | 1 | 1,000 | 0 | 0 |
South Street Corporation | Common | 840441109 | 112 | 1,548 | SH | | DFND | 1 | 1,548 | 0 | 0 |
South Street Corporation | Common | 840441109 | 39 | 534 | SH | | DFND | 1 | 534 | 0 | 0 |
Starwood Ppty | Common | 85571B105 | 8 | 400 | SH | | DFND | 1 | 400 | 0 | 0 |
Strongbridge Biopharma PLC | Common | BY25XL9US | 647 | 266,194 | SH | | DFND | 2 | 266,194 | 0 | 0 |
TG Therapeutics Inc. | Common | 88322Q108 | 2,641 | 50,773 | SH | | DFND | 2 | 50,773 | 0 | 0 |
Trillium Therapeutics Inc. | Common | 89620X506 | 2,570 | 174,699 | SH | | DFND | 2 | 174,699 | 0 | 0 |
The Kraft Heinz Company | Common | 500754106 | 105 | 3,035 | SH | | DFND | 1 | 3,035 | 0 | 0 |
The Kraft Heinz Company | Common | 500754106 | 42 | 1,199 | SH | | DFND | 1 | 1,199 | 0 | 0 |
Total SA | Common | 89151E109 | 99 | 2,360 | SH | | DFND | 1 | 2,360 | 0 | 0 |
Total SA | Common | 89151E109 | 21 | 500 | SH | | DFND | 1 | 500 | 0 | 0 |
uniQure N.V. | Common | N90064101 | 1,265 | 35,000 | SH | | DFND | 2 | 35,000 | 0 | 0 |
Upland Software, Inc. | Common | 91544A109 | 18,654 | 406,500 | SH | | DFND | 2 | 406,500 | 0 | 0 |
Valley National Bancorp | Common | 919794107 | 90 | 9,280 | SH | | DFND | 1 | 9,280 | 0 | 0 |
Valley National Bancorp | Common | 919794107 | 31 | 3,200 | SH | | DFND | 1 | 3,200 | 0 | 0 |
Vapotherm, Inc. | Common | 922107107 | 1,316 | 49,000 | SH | | DFND | 2 | 49,000 | 0 | 0 |
Verizon Communications | Common | 92343V104 | 78 | 1,320 | SH | | DFND | 1 | 1,320 | 0 | 0 |
Verizon Communications | Common | 92343V104 | 998 | 16,991 | SH | | DFND | 1 | 16,991 | 0 | 0 |
Verrica Pharmaceuticals, Inc. | Common | 92511W108 | 881 | 76,585 | SH | | DFND | 2 | 76,585 | 0 | 0 |
Viatris Inc. | Common | 92556V106 | 5 | 80 | SH | | DFND | 1 | 80 | 0 | 0 |
Viking Therapeutics, Inc. | Common | 92686J106 | 1,228 | 218,102 | SH | | DFND | 2 | 218,102 | 0 | 0 |
WABTEC | Common | 929740108 | 1 | 17 | SH | | DFND | 1 | 17 | 0 | 0 |
WABTEC | Common | 929740108 | 0 | 6 | SH | | DFND | 1 | 6 | 0 | 0 |
WP Carey | Common | 92936U109 | 423 | 6,000 | SH | | DFND | 1 | 6,000 | 0 | 0 |
Xenon Pharmaceuticals Inc. | Common | 98420N105 | 3,076 | 200,000 | SH | | DFND | 2 | 200,000 | 0 | 0 |
Zogenix, Inc. | Common | 98978L204 | 2,253 | 112,707 | SH | | DFND | 2 | 112,707 | 0 | 0 |